Overview

Single Injection Adductor Canal Block Versus Continuous Adductor Canal Infusion for Total Knee Arthroplasty

Status:
Completed
Trial end date:
2017-11-15
Target enrollment:
Participant gender:
Summary
Patients undergoing Primary Total Knee Arthroplasty will be randomized to receive either multimodal single injection adductor canal block with sham infusion catheter or continuous infusion of local anesthetic (control) for postoperative analgesia. Primary end point is pain scores at 30 hours post performance of block procedure.
Phase:
Early Phase 1
Details
Lead Sponsor:
Wake Forest University Health Sciences
Treatments:
Bupivacaine
Clonidine
Epinephrine
Epinephryl borate
Racepinephrine